These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33145353)

  • 21. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells.
    Lan X; Wu YZ; Wang Y; Wu FR; Zang CB; Tang C; Cao S; Li SL
    Int J Mol Med; 2013 Feb; 31(2):315-24. PubMed ID: 23233126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amarogentin regulates self renewal pathways to restrict liver carcinogenesis in experimental mouse model.
    Sur S; Pal D; Banerjee K; Mandal S; Das A; Roy A; Panda CK
    Mol Carcinog; 2016 Jul; 55(7):1138-49. PubMed ID: 26154024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of hepatitis B x-interacting protein in HepG2 cells enhances tumor-induced angiogenesis.
    Wang F; Fei H; Qi B; Yao S; Chang Z
    Mol Cell Biochem; 2012 May; 364(1-2):165-71. PubMed ID: 22209835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo.
    Sinha S; Pal K; Elkhanany A; Dutta S; Cao Y; Mondal G; Iyer S; Somasundaram V; Couch FJ; Shridhar V; Bhattacharya R; Mukhopadhyay D; Srinivas P
    Int J Cancer; 2013 Mar; 132(5):1201-12. PubMed ID: 22806981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublethal heat treatment of hepatocellular carcinoma promotes intrahepatic metastasis and stemness in a VEGFR1-dependent manner.
    Tan L; Chen S; Wei G; Li Y; Liao J; Jin H; Zou Y; Huang M; Peng Z; Guo Y; Peng S; Xu L; Kuang M
    Cancer Lett; 2019 Sep; 460():29-40. PubMed ID: 31173855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
    Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
    Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study.
    Ma D; Wang J; Liu L; Chen M; Wang Z
    BMC Cancer; 2020 Sep; 20(1):936. PubMed ID: 32993568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
    Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT
    J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines.
    Lirdprapamongkol K; Chiablaem K; Sila-Asna M; Surarit R; Bunyaratvej A; Svasti J
    Biochem Biophys Res Commun; 2012 Jun; 422(3):429-35. PubMed ID: 22580004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.
    Yan JJ; Zhang YN; Liao JZ; Ke KP; Chang Y; Li PY; Wang M; Lin JS; He XX
    Oncotarget; 2015 Oct; 6(30):29527-42. PubMed ID: 26336827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
    Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
    World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.
    Chai ZT; Kong J; Zhu XD; Zhang YY; Lu L; Zhou JM; Wang LR; Zhang KZ; Zhang QB; Ao JY; Wang M; Wu WZ; Wang L; Tang ZY; Sun HC
    PLoS One; 2013; 8(10):e77957. PubMed ID: 24194905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD133
    Liu K; Hao M; Ouyang Y; Zheng J; Chen D
    Sci Rep; 2017 Jan; 7():41499. PubMed ID: 28134312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model.
    Qiu YQ; Zhou J; Kang XS; Ding LM; Yu W; Tan FL; Deng DF
    Sci Rep; 2014 Mar; 4():4324. PubMed ID: 24632756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways.
    Zuo WH; Zeng P; Chen X; Lu YJ; Li A; Wu JB
    Sci Rep; 2016 Nov; 6():37499. PubMed ID: 27886213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA.
    Kong J; Kong J; Pan B; Ke S; Dong S; Li X; Zhou A; Zheng L; Sun WB
    PLoS One; 2012; 7(5):e37266. PubMed ID: 22615958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling.
    Liu P; Atkinson SJ; Akbareian SE; Zhou Z; Munsterberg A; Robinson SD; Bao Y
    Sci Rep; 2017 Oct; 7(1):12651. PubMed ID: 28978924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.
    Silkenstedt E; Arenas F; Colom-Sanmartí B; Xargay-Torrent S; Higashi M; Giró A; Rodriguez V; Fuentes P; Aulitzky WE; van der Kuip H; Beà S; Toribio ML; Campo E; López-Guerra M; Colomer D
    J Exp Clin Cancer Res; 2019 Nov; 38(1):446. PubMed ID: 31676012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells.
    Harjes U; Bridges E; McIntyre A; Fielding BA; Harris AL
    J Biol Chem; 2014 Aug; 289(33):23168-23176. PubMed ID: 24939870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.